Published in Eur Respir J on April 01, 1996
The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: relation to polysomnographic measurements of the apnea/hypopnea index. J Clin Sleep Med (2011) 1.26
A comparative study on the clinical and polysomnographic pattern of obstructive sleep apnea among obese and non-obese subjects. Ann Thorac Med (2012) 0.80
The prevalence of clinically significant sleep apnoea syndrome in The Netherlands. Thorax (1998) 0.77
Predictive value of clinical features for the obstructive sleep apnoea syndrome. Eur Respir J (1996) 1.91
Effect of supplemental nocturnal oxygen on gas exchange in patients with severe obstructive lung disease. N Engl J Med (1984) 1.88
Pathophysiology of obstructive sleep apnoea. Eur Respir J (1995) 1.85
Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J (2000) 1.80
Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med (1997) 1.76
Hypoxaemia during chest physiotherapy in patients with cystic fibrosis. Ir J Med Sci (1986) 1.74
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax (2009) 1.45
Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J (2009) 1.43
Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. Chest (2000) 1.35
Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis (1982) 1.18
Public health and medicolegal implications of sleep apnoea. Eur Respir J (2002) 1.14
Is sleep apnoea more common in North America? Lancet (1982) 1.14
Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J (1994) 1.11
Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J (2001) 1.10
Bed partners' assessment of nasal continuous positive airway pressure therapy in obstructive sleep apnea. Chest (1997) 1.01
Effects of positive airway pressure on upper airway dilator muscle activity and ventilatory timing. J Appl Physiol (1985) (1996) 1.00
Acute stridor due to an upper tracheal membrane following endotracheal intubation. Eur Respir J (1999) 1.00
The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction. Eur Respir J (2008) 0.99
Nocturnal deaths among patients with chronic bronchitis and emphysema. Br Med J (Clin Res Ed) (1984) 0.99
Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J (1999) 0.98
Reflex respiratory response to changes in upper airway pressure in the anaesthetized rat. J Physiol (2001) 0.97
Obstructive sleep apnea following topical oropharyngeal anesthesia in loud snorers. Am Rev Respir Dis (1991) 0.97
Controlled oxygen therapy and carbon dioxide retention during exacerbations of chronic obstructive pulmonary disease. Lancet (2001) 0.97
Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis (1993) 0.96
Haemodynamic effects of nasal continuous positive airway pressure in severe congestive heart failure. Eur Respir J (1995) 0.94
Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax (2004) 0.93
A one-year prospective audit of an asthma education programme in an out-patient setting. Ir Med J (1997) 0.92
Adipose tissue in obesity and obstructive sleep apnoea. Eur Respir J (2011) 0.91
Ventilation and gas exchange during sleep in patients with interstitial lung disease. Thorax (1986) 0.91
Theophylline in obstructive sleep apnea. A double-blind evaluation. Chest (1992) 0.90
Comparison of three auto-adjusting positive pressure devices in patients with sleep apnoea. Eur Respir J (2006) 0.89
Beneficial effect of oxygen in primary alveolar hypoventilation with central sleep apnea. Am Rev Respir Dis (1982) 0.88
Comparison of a limited computerized diagnostic system (ResCare Autoset) with polysomnography in the diagnosis of obstructive sleep apnoea syndrome. Eur Respir J (1996) 0.85
Ventilation and gas exchange during sleep and exercise in severe COPD. Chest (1996) 0.85
Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis (1983) 0.85
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Postgrad Med J (2009) 0.85
Compliance at night with low flow oxygen therapy: a comparison of nasal cannulae and Venturi face masks. Thorax (1995) 0.84
Comparison of oxygen desaturation during sleep and exercise in patients with cystic fibrosis. Chest (1991) 0.84
Honeycomb cysts in idiopathic pulmonary haemosiderosis: high-resolution CT appearances in two adults. Br J Radiol (2008) 0.84
Upper airway obstruction during sleep in normal subjects after selective topical oropharyngeal anesthesia. Am Rev Respir Dis (1987) 0.83
Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis (1986) 0.82
Late-onset central hypoventilation syndrome: a family genetic study. Eur Respir J (2007) 0.82
Sarcoidosis presenting as upper extremity venous thrombosis. Thorax (2003) 0.82
Efficacy of nasal continuous positive airway pressure therapy in chronic heart failure: importance of underlying cardiac rhythm. Thorax (1998) 0.82
Sleep-related breathing disorders: definitions and measurements. Eur Respir J (2000) 0.81
Portable monitoring in sleep apnoea: the way forward? Eur Respir J (2011) 0.81
Towards automated sleep state estimation using a Holter-oximeter. Conf Proc IEEE Eng Med Biol Soc (2007) 0.80
Impaired detection of added inspiratory resistance in patients with obstructive sleep apnea. Am Rev Respir Dis (1984) 0.80
Treatment of Robin sequence with nasal CPAP. J Laryngol Otol (1995) 0.80
Reversible hypercapnia in acute exacerbations of chronic obstructive pulmonary disease (COPD). Eur Respir J (1993) 0.80
Topical oropharyngeal anesthesia in patients with obstructive sleep apnea. Am J Respir Crit Care Med (1995) 0.79
Upper lobe bronchiectasis in the yellow nail syndrome: report of a case. Ir J Med Sci (1984) 0.79
Compliance with nasal CPAP therapy for obstructive sleep apnoea: how much is enough? Eur Respir J (1997) 0.79
Paradoxical vocal cord motion causing stridor after thyroidectomy. Thorax (2000) 0.78
Comparison of nebulized and sprayed topical anaesthesia for fibreoptic bronchoscopy. Eur Respir J (1992) 0.78
Resolution of obstructive sleep apnoea with growth in the Robin sequence. Eur Respir J (1998) 0.77
Clinical prediction of the sleep apnea syndrome. Sleep Med Rev (1997) 0.77
Oxygen desaturation during sleep and exercise in patients with severe chronic obstructive pulmonary disease. Respir Med (1995) 0.76
Malignant chondroid syringoma presenting as multiple pulmonary nodules. Thorax (1997) 0.75
Arousal in the sleep apnoea syndrome: a mixed blessing? Eur Respir J (1998) 0.75
Effect of obesity in patients with coronary artery disease. Lancet (2006) 0.75
Continuous non-invasive monitoring of evolving acute severe asthma during sleep. Thorax (1994) 0.75
An unusual cause of orthopnoea. Postgrad Med J (1996) 0.75
Multifactorial hypokalaemia in a beer drinker. Ir J Med Sci (1993) 0.75
Chronic respiratory failure--evolving concepts. Ir J Med Sci (1988) 0.75
Sleep apnoea: a two-year experience. Ir Med J (1988) 0.75
Sleep HERMES: a European training project for respiratory sleep medicine. Eur Respir J (2011) 0.75
Potassium and ventilation during exercise above and below the ventilatory threshold. Respir Physiol (1997) 0.75
Sleep apnoea and driving risk. European Respiratory Society Task Force on "Public Health and Medicolegal Implications of Sleep Apnoea". Eur Respir J (1999) 0.75
A rapid desktop theophylline assay. Evaluation of use in clinical management. Chest (1997) 0.75
Home mechanical ventilation. Ir Med J (2005) 0.75
The effects of atropine and glycopyrrolate on heart rates in conscious mature goats. Vet Surg (1996) 0.75
Controlling passive smoking through legislation in Ireland: an attack on civil liberty or good public health policy? Eur Respir J (2004) 0.75
Broncholithiasis: bronchoscopic vs. surgical management. Respir Med (1990) 0.75
Sleep apnoea in the British Isles. Lancet (1986) 0.75
Sleepiness, sleep apnoea and driving risk. Ir Med J (2001) 0.75
Educating the patient with asthma. Ir J Med Sci (1989) 0.75
The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome. Eur Respir J (2009) 0.75
Nocturnal nasal intermittent positive pressure ventilation (NIPPV) therapy for chronic respiratory failure: long-term effects. Ir Med J (2000) 0.75
Sleep and medical disorders. Ir Med J (1994) 0.75
Pulmonary fibrosis in polymyositis with the Jo-1 syndrome: an unusual mode of presentation. Respir Med (1998) 0.75
Improved ventilatory function associated with relief of chest pain in a patient with Kartagener's syndrome treated by subcutaneous analgesia. Respir Med (2004) 0.75